Viewing Study NCT01561833


Ignite Creation Date: 2025-12-25 @ 3:07 AM
Ignite Modification Date: 2025-12-26 @ 1:46 AM
Study NCT ID: NCT01561833
Status: COMPLETED
Last Update Posted: 2020-08-13
First Post: 2012-03-13
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Pilot Study of Sorafenib Examining Biomarkers in Refractory or Relapsed T-Cell Lymphoma Patients
Sponsor: Yale University
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2009-10
Start Date Type: None
Primary Completion Date: 2013-05
Primary Completion Date Type: ACTUAL
Completion Date: 2013-06
Completion Date Type: ACTUAL
First Submit Date: 2012-03-13
First Submit QC Date: None
Study First Post Date: 2012-03-23
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2016-06-15
Results First Submit QC Date: None
Results First Post Date: 2020-08-13
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-08-12
Last Update Post Date: 2020-08-13
Last Update Post Date Type: ACTUAL